期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

《中国药物应用与监测》开通优秀论文发表绿色通道

下载PDF
导出
摘要 为了最大限度地缩短优秀论文的刊发周期，维护其首发权，同时，更快捷地传播先进的新技术、新成果，本刊特开通优秀论文发表绿色通道，优先刊登下列几类论文：
出处 《中国药物应用与监测》 CAS 2013年第6期341-341,共1页 Chinese Journal of Drug Application and Monitoring
关键词 论文发表 绿色通道 监测 应用 药物 中国 优秀论文
分类号 R197.32 [医药卫生—卫生事业管理]
  • 相关文献

参考文献15

  • 1抗癫痫药物应用专家共识[J].中华神经科杂志,2011,44(1):56-65. 被引量：184
  • 2Bj?rnsson E,Olsson R. Suspected drug-induced liver fatalities reported to the WHO database[J].{H}Digestive and Liver Disease,2006,(01):33-38.
  • 3Rimmer EM,Richens A. An update on sodium valproate[J].{H}PHARMACOTHERAPY,1985,(03):171-184.
  • 4希恩. C.斯威曼;李大魁;金有豫;汤光.马丁代尔药物大典[M]{H}北京:化学工业出版社,2009399-403.
  • 5Cepelak I,Zani?Grubisi?T,Mandusi?A. Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children[J].{H}Clinica Chimica Acta,1998,(02):121-127.
  • 6Ji Q,Shi X,Lin R. Participation of lipid transport and fatty acid metabolism in valproate sodium-induced hepatotoxicity in HepG2 cells[J].{H}TOXICOLOGY IN VITRO,2010,(04):1086-1091.
  • 7Noven Therapeutics, LLC. STAVZOR (valproic acid) capsule, delayed release[EB/OL].http://dailymed.nlm.nih.gov/dailymed/lookup.cfm setid=95a4ddd8-b76a-4128-b2ed-8a36cd5738f9.html,2013.
  • 8Beydoun A,Sackellares JC,Shu V. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy:a double-blind, concentration-response design clinical trial.Depakote Monotherapy for Partial Seizures Study Group[J].{H}NEUROLOGY,1997,(01):182-188.
  • 9Angélica Fajardo,Francisco Olmos,Lina Sarmiento. Valproic acid and the risk of perioperative bleeding. Case report and literature review[J].Rev Colomb Anestesiol,2013,(01):61-64.
  • 10Hui-Chuan Hsu,Hsiang-Kuang Tseng,Shen-Chuan Wang. Valproic acid-induced agranulocytosis[J].Int J Gerontol,2009,(02):137-139.

二级参考文献20

  • 1Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults : expert opinion, 2005. Epilepsy Behav, 2005, 7 Suppl 1 : S1-64.
  • 2French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I. Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2004, 62: 1252-1260.
  • 3Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia, 1998, 39 : 5-17.
  • 4Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342: 314-319.
  • 5Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet, 2007, 369 : 1016-1026.
  • 6Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus ahernative monotherapy in patients with partial epilepsy failing on a single drug: a muhicentre, randomized, pragmatic controlled trial. Epilepsy Res, 2003, 57: 1-13.
  • 7Kwan P, Brodie MJ. Epilepsy after the first drug fails : substitution or add-on? Seizure, 2000, 9: 464468.
  • 8Hauser WA. Seizure disorders: the changes with age. Epilepsia, 1992, 33 Suppl 4: $6-14.
  • 9Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352: 1970-1973.
  • 10Faught E. Monotherapy in adults and elderly persons. Neurology, 2007, 69 (24 Suppl 3 ) : $3-$9.

共引文献183

中国药物应用与监测
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部